#222 AFib Stroke Prevention: WATCHMAN, DOACs, and the CHAMPION-AF Trial | Beyond Journal Club Segment with NEJM Group
31m | Oct 28, 2026If your patient asks you about a left atrial appendage closure device, what should you tell them?Ā Ā
Ā In the latest episode of the Beyond Journal Club podcast from CORE IM and NEJM Group, the hosts will help you:Ā
- Understand the trade-offs: stroke prevention, bleeding, procedural risks, and medications afterward.Ā
- Build clinical judgment: weigh which approach may better serve the individual patient, beyond the trialās headline.Ā
- Learn from thoughtful counseling: hear how you might discuss the evidence, acknowledge uncertainty, and explore what matters to your patients.
š¹Sponsor: ACP MKSAP Oakstone CME
Use the code "CORE25" for 25% off: https://www.coreimpodcast.com/MKSAP7ā
š¹Transcript and Show Notes Ā
01:09 | What the Watchman is, and why it should work?
05:58 | The checkered history: PROTECT-AF and PREVAIL
09:06 | The plot continues: PRAGUE-17, OPTION, OCEAN, and CLOSURE-AF
12:35 | CHAMPION-AF: the biggest test yet
15:03 | Reading the fine print
19:23 | A local solution to a systemic problem
22:45 | How patients hear about it
25:44 | So what do we tell our patients?
29:52 | Takeaways
Tags: IMCore, Internal Medicine, Medical Education, WATCHMAN device, Atrial Fibrillation, Cardiology, DOAC Anticoagulation, Primary Care, Hospital Medicine
Find the best disability insurance for you: https://www.patternlife.com/disability-insurance?campid=497840
Our Sponsors:
* Check out ElevenReader and use my code PODCAST for a great deal: https://elevenreader.io
Advertising Inquiries: https://redcircle.com/brands
Privacy & Opt-Out: https://redcircle.com/privacy
